Public-registry site landscape for NCT05935085, a Atopic Dermatitis Eczema study sponsored by AnaptysBio, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05935085 (registry record) |
| Sponsor | AnaptysBio, Inc. |
| Condition(s) | Atopic Dermatitis Eczema |
| Phase | PHASE2 |
| Listed sites | 78 |
| Site countries | United States, Australia, Canada, Czechia, Georgia, New Zealand, Poland |
Eichor generates a preliminary site-risk snapshot for NCT05935085 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →